Answers are grounded in this paper and cite their sources.
Modified subtype and stage inference identifies distinct Alzheimer's disease subtypes, highlighting biomarker correlations.
Motivation: Subtype and Stage Inference (SuStaIn) model is widely used to reveal spatiotemporal heterogeneity in cross-sectional datasets. But SuStaIn does not account for correlations between biomarkers. Goal(s): We attempt to modify SuStaIn model to utilize highly correlated biomarkers in the analysis of neurodegenerative diseases' heterogeneity. Approach: We propose Multi-Parametric SuStaIn (MP-SuStaIn), an alternative SuStaIn model that incorporates biomarker correlations into spatiotemporal analysis. We apply MP-SuStaIn to analyze Alzheimer's disease (AD) based on multiple morphological features using the ADNI dataset. Results: MP-SuStaIn identified three subtypes of AD, each with distinct progression patterns, morphological characteristics, clinical symptoms, and prognostic results. Impact: We identified three subtypes of Alzheimer's disease with distinct progression patterns and morphological characteristics by using multiple brain morphologic biomarkers and a modified Subtype and Stage Inference model, which can analyze the spatiotemporal heterogeneity of neurodegenerative diseases.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: